Electroporation-mediated genetic vaccination for antigen mapping: Application to Plasmodium falciparum VAR2CSA protein

Bioelectrochemistry

Volumn 87, Issue , 2012, Pages 132-137

  Bordbar, Bita ^a,b   Gnidehou, Sédami ^a,b   Ndam, Nicaise Tuikue ^a,b,e   Doritchamou, Justin ^e   Moussiliou, Azizath ^e   Quiviger, Mickael ^a,b   Deloron, Philippe ^a,b   Scherman, Daniel ^a,c,d   Bigey, Pascal ^a,c,d  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^c PSL RESEARCH UNIVERSITY   (France)

^d Centre National de la Recherche Scientifique   (France)

^e UNIVERSITY OF ABOMEY CALAVI   (Benin)

Author keywords

Electrotransfer; Genetic immunization; Placental malaria; Plasmid electroporation

Indexed keywords

DELIVERY TECHNIQUES; DNA PLASMIDS; DNA TRANSFER; ELECTROPORATION; ELECTROTRANSFER; GENETIC VACCINATION; IMMUNOGENIC PROPERTIES; N-TERMINALS; NONVIRAL VECTORS; PLACENTAL MALARIA; PLASMID DNA; PLASMODIUM FALCIPARUM;

ANTIGENS; GENE THERAPY; GENETIC ENGINEERING; RECOMBINANT PROTEINS; TISSUE; VACCINES;

DISEASES;

DNA VACCINE; DUFFY BINDING PROTEIN; ERYTHROCYTE MEMBRANE PROTEIN 1; UNCLASSIFIED DRUG; VAR2CSA PROTEIN;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DNA IMMUNIZATION; ELECTROPORATION; EPITOPE MAPPING; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; MALARIA FALCIPARUM; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLACENTA MALARIA; PLASMODIUM FALCIPARUM; RABBIT;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ELECTROPORATION; FEMALE; GENE TRANSFER TECHNIQUES; IMMUNIZATION; MALARIA VACCINES; MALARIA, FALCIPARUM; MICE; PLACENTA; PLASMIDS; PLASMODIUM FALCIPARUM; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; RABBITS; VACCINES, DNA;

MUS; ORYCTOLAGUS CUNICULUS; PLASMODIUM FALCIPARUM;

EID: 84865159072     PISSN: 15675394     EISSN: 1878562X     Source Type: Journal    
DOI: 10.1016/j.bioelechem.2011.12.009     Document Type: Article

References (39)

1. Kutzler M.A., Weiner D.B. DNA vaccines: ready for prime time?. Nat. Rev. Genet. 2008, 9:776-788.
2. Trollet C., Bloquel C., Scherman D., Bigey P. Electrotransfer into skeletal muscle for protein expression. Curr. Gene Ther. 2006, 6:561-578.
3. Neumann E., Schaefer-Ridder M., Wang Y., Hofschneider P.H. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J. 1982, 1(7):841-845.
4. Escoffre J.M., Portet T., Wasungu L., Teissié J., Dean D., Rols M.P. What is (still not) known of the mechanism by which electroporation mediates gene transfer and expression in cells and tissues. Mol. Biotechnol. 2009, 41:286-295.
5. Escoffre J.M., Portet T., Favard C., Teissié J., Dean D.S., Rols M.P. Electromediated formation of DNA complexes with cell membranes and its consequences for gene delivery. Biochim. Biophys. Acta. 2011, 1808:1538-1543.
6. Andre F.M., Mir L.M. Nucleic acids electrotransfer in vivo: mechanisms and practical aspects. Curr. Gene Ther. 2010, 10:267-280.
7. Golzio M., Escoffre J.M., Portet T., Mauroy C., Teissié J., Dean D.S., Rols M.P. Observations of the mechanisms of electromediated DNA uptake-from vesicles to tissues. Curr. Gene Ther. 2010, 10:256-266.
8. Rice J., Ottensmeier C.H., Stevenson F.K. DNA vaccines: precision tools for activating effective immunity against cancer. Nat. Rev. Cancer. 2008, 8:108-120.
9. Liu M.A. Immunologic basis of vaccine vectors. Immunity 2010, 33:504-515.
10. Rochard A., Scherman D., Bigey P. Genetic immunization with plasmid DNA mediated by electrotransfer. Hum. Gene Ther. 2011, 22:789-798.
11. Mariana I., Kawalekar O., Shedlock D.J., Muthumani K., Weiner D.B. DNA vaccines for targeting bacterial infections. Expert Rev. Vaccines. 2010, 9:747-763.
12. Alexandrenne C., Wijkhuisen A., Dkhissi F., Hanoux V., Créminon C., Boquet D., Couraud J.Y. Generating antibodies against the native form of the human prion protein (hPrp) in wild-type animals: a comparison between DNA and protein immunization. J. Immunol. Methods. 2009, 341:41-49.
13. Chua K.Y., K.Y, Kuo I.C., Huang C.H. DNA vaccines for the prevention and treatment of allergy. Curr. Opin. Allergy Clin. Immunol. 2009, 9:50-54.
14. Yang L., Cheong N., Wang D.Y., Lee B.W., Kuo I.C., Huang C.H., Chua K.Y. Generation of monoclonal antibodies against Blo t 3 using DNA immunization with in vivo electroporation. Clin. Exp. Allergy 2003, 33:663-668.
15. Salanti A., Staalsoe T., Lavstsen T., Jensen A.T., Sowa M.P., Arnot D.E., Hviid L., Theander T.G. Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria. Mol. Microbiol. 2003, 49:179-191.
16. Tuikue Ndam N.G., Salanti A., Bertin G., Dahlbäck M., Fievet N., Turner L., Gaye A., Theander T., Deloron P. High level of var2csa transcription by Plasmodium falciparum isolated from the placenta. J. Infect. Dis. 2005, 192:331-335.
17. Duffy M.F., Caragounis A., Noviyanti R., Kyriacou H.M., Choong E.K., Boysen K., Healer J., Rowe J.A., Molyneux M.E., Brown G.V., Rogerson S.J. Transcribed var genes associated with placental malaria in Malawian women. Infect. Immun. 2006, 74:4875-4883.
18. Brabin B.J., Romagosa C., Abdelgalil S., Menéndez C., Verhoeff F.H., McGready R., Fletcher K.A., Owens S., D'Alessandro U., Nosten F., Fischer P.R., Ordi J. The sick placenta-the role of malaria. Placenta 2004, 25:359-378.
19. Ricke C.H., Staalsoe T., Koram K., Akanmori B.D., Riley E.M., Theander T.G., Hviid L. Plasma antibodies from malaria-exposed pregnant women recognize variant surface antigens on Plasmodium falciparum-infected erythrocytes in a parity-dependent manner and block parasite adhesion to chondroitin sulfate A. J. Immunol. 2000, 165:3309-3316.
20. Fried M., Nosten F., Brockman A., Brabin B.J., Duffy P.E. Maternal antibodies block malaria. Nature 1998, 395:851-852.
21. O'Neil-Dunne I., Achur R.N., Agbor-Enoh S.T., Valiyaveettil M., Naik R.S., Ockenhouse C.F., Zhou A., Megnekou R., Leke R., Taylor D.W. Gravidity-dependent production of antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to placental chondroitin sulfate proteoglycan during pregnancy. Infect. Immun. 2001, 69:7487-7492.
22. Ofori M.F., Staalsoe T., Bam V., Lundquist M., David K.P., Browne E.N., Akanmori B.D., Hviid L. Expression of variant surface antigens by Plasmodium falciparum parasites in the peripheral blood of clinically immune pregnant women indicates ongoing placental infection. Infect. Immun. 2003, 71:1584-1586.
23. Staalsoe T., Megnekou R., Fievét N., Ricke C.H., Zornig H.D., Leke R., Taylor D.W., Deloron P., Hviid L. Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia. J. Infect. Dis. 2001, 184:618-626.
24. Fernandez P., Viebig N.K., Dechavanne S., Lépolard C., Gysin J., Scherf A., Gamain B. Var2CSA DBL6-epsilon domain expressed in HEK293 induces limited cross-reactive and blocking antibodies to CSA binding parasites. Malar. J. 2008, 7:170.
25. Nielsen M.A., Pinto V.V., Resende M., Dahlbäck M., Ditlev S.B., Theander T.G., Salanti A. Induction of adhesion-inhibitory antibodies against placental Plasmodium falciparum parasites by using single domains of VAR2CSA. Infect. Immun. 2009, 77:2482-2487.
26. P. Bigey, S. Gnidehou, J. Dorichamou, M. Quiviger, F. Viwami, A. Couturier, A. Salanti, A. M.A. Nielsen, D. Scherman, P. Deloron, N. Tuikue Ndam, The NTS-DBL2X region of VAR2CSA induces cross-reactive antibodies that inhibit adhesion of several Plasmodium falciparum isolates to Chondroitin-Sulfate A, J. Inf. Dis. 204 (7) (2011) 1125-1133.
27. Khunrae P., Dahlback M., Nielsen M.A., Andersen G., Ditlev S.B., Resende M., Pinto V.V., Theander T.G., Higgins M.K., Salanti A. Full-length recombinant Plasmodium falciparum VAR2CSA binds specifically to CSPG and induces potent parasite adhesion-blocking antibodies. J. Mol. Biol. 2010, 397:826-834.
28. Trollet C., Pereira Y., Burgain A., Litzler E., Mezrahi M., Seguin J., Manich M., Popoff M.R., Scherman D., Bigey P. Generation of high-titer neutralizing antibodies against botulinum toxins A, B and E by DNA electrotransfer. Infect. Immun. 2009, 77:2221-2229.
29. Cranmer S.L., Magowan C., Liang J., Coppel R.L., Cooke B.M. An alternative to serum for cultivation of Plasmodium falciparum in vitro. Trans. R. Soc. Trop. Med. Hyg. 1997, 91:363-365.
30. Haase R.N., Megnekou R., Lundquist M., Ofori M.F., Hviid L., Staalsoe T. Plasmodium falciparum parasites expressing pregnancy-specific variant surface antigens adhere strongly to the choriocarcinoma cell line BeWo. Infect. Immun. 2006, 74:3035-3038.
31. Trager W., Jensen J.B. Human malaria parasites in continuous culture. Science 1976, 193:673-675.
32. Srivastava A., Gangnard S., Round A., Dechavanne S., Juillerat A., Raynal B., Faure G., Baron B., Ramboarina S., Singh S.K., Belrhali H., England P., Lewit-Bentley A., Scherf A., Bentley G.A., Gamain B. Full-length extracellular region of the var2CSA variant of PfEMP1 is required for specific, high-affinity binding to CSA. Proc. Natl. Acad Sci. U.S.A. 2010, 107:4884-4889.
33. Morris G.E. Epitope Mapping Protocols 1996, 66:1-9. Humana Press, Totowa, NJ.
34. Cho H.S., Mason K., Ramyar1 K.X., Stanley A.M., Gabelli S.B., Denney D.W., Leahy D.J. Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab. Nature 2003, 421:756-760.
35. Lammerts van Bueren J.J., Bleeker W.K., Brännström A., von Euler A., Jansson M., Peipp M., Schneider-Merck T., Valerius T., van de Winkel J.G.J., Parren P.W.H.I. The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility. Proc. Natl. Acad. Sci. USA 2008, 105:6109-6114.
36. Doria-Rose N.A., Haigwood N.L. DNA vaccine strategies: candidates for immune modulation and immunization regimens. Methods 2003, 31:207-216.
37. Frelin L., Ahlen G., Alheim M., Weiland O., Barnfield C., Liljestrom P., Sallberg M. Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene. Gene Ther. 2004, 11:522-533.
38. Geissler M., Bruss V., Michalak S., Hockenjos B., Ortmann D., Offensperger W.B., Wands J.R., Blum H.E. Intracellular retention of hepatitis B virus surface proteins reduces interleukin-2 augmentation after genetic immunizations. J. Virol. 1999, 73:4284-4292.
39. Ashok M.S., Rangarajan P.N. Protective efficacy of a plasmid DNA encoding Japanese encephalitis virus envelope protein fused to tissue plasminogen activator signal sequences: studies in a murine intracerebral virus challenge model. Vaccine 2002, 20:1563-1570. positive control (NTS-DBL1X-6E{open}).